The National Academies of Sciences, Engineering, and Medicine are private, nonprofit institutions that provide independent, objective analysis and advice to the nation and conduct other activities to solve complex problems and inform public policy decisions related to science, technology, and medicine.
Many of the studies the Academies undertake are requested by federal agencies and independent organizations; others begin as specific mandates from Congress. The Academies also convene a series of forums, roundtables, and standing committees to facilitate discussion, discovery, and cross-disciplinary thinking.
Note: The National Academies of Sciences, Engineering, and Medicine Health and Medicine Division was previously called the Institute of Medicine (IOM).
Overview: A National Strategy for the Elimination of Hepatitis B and C
The National Academies of Sciences, Engineering, and Medicine’s (National Academies) Committee on a National Strategy for the Elimination of Hepatitis B & C explores the elimination of hepatitis B and C from the United States in two phases. First, it considered the feasibility of elimination as a goal, with attention to social and logistical aspects of feasibility as well as scientific ones. The Phase One report was released in April 2016. In Phase Two, the committee outlined a strategy to reach the goals identified in the first report. The Phase Two report was released in March 2017. In this report, the committee recommends actions to specific stakeholders, with some attention to the role of correctional facilities, primary care, and community health centers.
NVHR was pleased to be a sponsor of the second phase of work by the National Academies, along with the Centers for Disease Control and Prevention’s Division of Viral Hepatitis, the Office of Minority Health, the Division of Cancer Prevention and Control within CDC, the American Association for the Study of Liver Disease, and the Infectious Diseases Society of America. The study closely aligns with our mission of fighting, and ultimately ending, the hepatitis B and C epidemics in the United States. We believe the final recommendations provide the necessary call to action to achieve elimination goals.
Phase I Report: Eliminating the Public Health Problem of Hepatitis B and C in the United States
On April 11, 2016, the National Academies released its Phase One report Eliminating the Public Health Problem of Hepatitis B and C in the U.S. This report explores the barriers that must be overcome to eliminate hepatitis B and C in the United States. The report reaffirms that hepatitis B and C elimination can be achieved with sufficient resources, commitment, and strategies.
Phase II Report: A National Strategy for the Elimination of Hepatitis B and C
On March 28, 2017, the National Academies released the Phase 2 report, A National Strategy for the Elimination of Hepatitis B and C.
In Phase 2, the National Academies confirms that elimination of hepatitis B and C in the United States is feasible and outlines specific actions to hasten the end of the diseases. Click here for NVHR’s fact sheet on the national strategy for elimination.
Phase II Meeting: National Strategy on the Elimination of Hepatitis B & C
This meeting of the National Academies of Sciences Committee on a National Strategy for the Elimination of Hepatitis B & C took place from June 8-9, 2016, in Washington, D.C. It focused on screening and referrals to care, and on innovative financing for hepatitis C treatments.
Click here for the agenda and presentations from the meeting.
- HHS Viral Hepatitis National Strategic Plan: A Roadmap to Elimination for the United States – 2021-2025
- HHS Mapping Hepatitis Elimination in Action
- Coalition for Global Hepatitis Alliance National Elimination Profiles: Comparing US and Canada
Published Elimination Plans
- New York State Hepatitis C Elimination Plan (2021)
- We Treat Hep C Michigan (2021)
- Zero is Possible Indiana (2020)
- Hep Free Hawaii (2020)
- Hep C Free Louisiana Plan (2019)
- Hep C Free WA Plan (2019)
NVHR Advocacy and Analysis
- Response from HHS: Assistant Secretary for Health, Dr. Rachel Levine Replies to Provider Advocates (May 2021)
- NVHR Sign-On Letter: Provider Advocates letter to Assistant Secretary for Health (April 2021)
- NVHR/CHLPI Research Poster: State Policies Limiting Progress Towards HCV Elimination in the U.S. (November 2020)
- NVHR/O’Neill Institute Research Poster: Models to Eliminate Viral Hepatitis in Four U.S. States (November 2020)
- NVHR Research Poster: Engaging People with Lived Experience in Viral Hepatitis Elimination (November 2020)